Streetbeat News

Analyst Ratings

HUBG

Susquehanna analyst Bascome Majors has maintained a Neutral rating on Hub Group (NASDAQ:HUBG) but has cut the price target from $97 to $49.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:12 pm

COCO

Goldman Sachs analyst Bonnie Herzog has maintained a Buy rating on Vita Coco (NASDAQ:COCO) but reduced the price target from $32 to $28.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:06 pm

SOFI

Goldman Sachs analyst Michael Ng has maintained a Neutral rating on SoFi Technologies (SOFI) and increased the price target from $7 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:04 pm

MBIN

Raymond James analyst Daniel Tamayo has reaffirmed a Strong Buy rating on Merchants Bancorp (NASDAQ:MBIN) and increased the price target from $44 to $55.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:04 pm

KGS

Raymond James analyst James Rollyson has reaffirmed an Outperform rating on Kodiak Gas Services (NYSE:KGS) and increased the price target from $23 to $25.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:02 pm

OLN

Goldman Sachs analyst Duffy Fischer has maintained a Neutral rating on Olin Corporation (NYSE:OLN) and increased the price target from $55 to $61.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:02 pm

FFIN

First Finl Bankshares (NASDAQ:FFIN) has been the subject of diverse analyst ratings over the past three months, with 4 indifferent ratings in total and 1 in the last 30 days. Analysts have raised their 12-month price targets, with an average of $32.25, reflecting a 9.32% increase from the previous $29.50. The company operates in community banking in Texas and has shown a -2.08% revenue decline as of December 31, 2023, but outperforms industry averages in net margin, ROE, and ROA, and has a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm

NTRA

Goldman Sachs analyst Matthew Sykes has reaffirmed a Buy rating on Natera (NASDAQ:NTRA) and increased the price target from $64 to $80.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:01 pm

OHI

Omega Healthcare Invts (NYSE:OHI) has been the subject of varying opinions from 5 analysts over the past three months, with recent ratings showing 1 bullish and 3 indifferent stances. The average 12-month price target is now $33.00, down from $34.00, with a high estimate of $36.00 and a low of $31.00. Analysts from Deutsche Bank, B of A Securities, Mizuho, Truist Securities, and Wells Fargo have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Omega Healthcare Investors Inc is a REIT focusing on long-term healthcare facilities, aiming to grow through M&A and maintain high care standards. The company has shown a revenue growth rate of 1.09% as of September 30, 2023, a net margin of 37.76%, an ROE of 2.51%, an ROA of 0.97%, and a debt-to-equity ratio of 1.44.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm

C

Nine analysts have recently updated their ratings on Citigroup (NYSE:C), with a mix of bullish and indifferent stances. The average 12-month price target is now $64.44, up from $59.00, with a high estimate of $93.00 and a low of $47.00. Analysts from firms including Morgan Stanley, Oppenheimer, Piper Sandler, HSBC, Wolfe Research, Barclays, and Goldman Sachs have raised their price targets. Citigroup's financial performance shows challenges with negative revenue trends, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 2:01 pm